The North America cancer vaccines market is expected to maintain a significant position in the global landscape through 2031, supported by the rising incidence of cancer, substantial healthcare expenditure, advanced research infrastructure, and increasing investments in innovative cancer immunotherapies. The region comprises the US, Canada, and Mexico and held a significant share of the global...

The US cancer vaccines market represents a key component of the North American landscape, supported by the high prevalence of cancer, sophisticated healthcare infrastructure, strong pharmaceutical capabilities, and considerable spending on oncology research and development. According to The Insight Partners, the United States is a key market, with growth supported by the increasing prevalence...

According to the latest report published by Data Bridge Market Research, the  Cancer Immunotherapy Market The global cancer immunotherapy market size was valued at USD 95.69 billion in 2024 and is expected to reach USD 28.27 billion by 2032, at a CAGR of 15.50% during the forecast period This growth is driven by factors such as the increasing prevalence of cancer worldwide,...